Pacific Biosciences of California, Inc. (PACB)

1.885 +0.06 (+3.57%) USD  |  NASDAQ  |  Dec 24, 12:59
1.885 0.00 (0.00%) After-Hours: 13:59
More

Pacific Biosciences of California SG&A Expense (TTM): 149.08M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PACB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Bruker Corp. 946.60M
ICU Medical, Inc. 628.25M
West Pharmaceutical Services, Inc. 371.90M
Clearpoint Neuro, Inc. 29.78M
Intellia Therapeutics, Inc. 119.17M